Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trial. (Q35462240)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25592632 AND SRC:MED&resulttype=core&format=json

28 February 2020

title

Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25592632 AND SRC:MED&resulttype=core&format=json

28 February 2020

main subject

phase II clinical trial

0 references

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25592632 AND SRC:MED&resulttype=core&format=json

28 February 2020

Eva Szabo

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25592632 AND SRC:MED&resulttype=core&format=json

28 February 2020

Giuseppe Giaccone

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25592632 AND SRC:MED&resulttype=core&format=json

28 February 2020

16

Jane B Trepel

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25592632 AND SRC:MED&resulttype=core&format=json

28 February 2020

10

Corey A Carter

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25592632 AND SRC:MED&resulttype=core&format=json

28 February 2020

author name string

Arun Rajan

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25592632 AND SRC:MED&resulttype=core&format=json

28 February 2020

Arlene Berman

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25592632 AND SRC:MED&resulttype=core&format=json

28 February 2020

Yusuke Tomita

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25592632 AND SRC:MED&resulttype=core&format=json

28 February 2020

Christina Brzezniak

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25592632 AND SRC:MED&resulttype=core&format=json

28 February 2020

Min-Jung Lee

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25592632 AND SRC:MED&resulttype=core&format=json

28 February 2020

Sunmin Lee

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25592632 AND SRC:MED&resulttype=core&format=json

28 February 2020

Alexander Ling

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25592632 AND SRC:MED&resulttype=core&format=json

28 February 2020

Aaron J Spittler

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25592632 AND SRC:MED&resulttype=core&format=json

28 February 2020

Udayan Guha

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25592632 AND SRC:MED&resulttype=core&format=json

28 February 2020

Yisong Wang

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25592632 AND SRC:MED&resulttype=core&format=json

28 February 2020

Paul Meltzer

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25592632 AND SRC:MED&resulttype=core&format=json

28 February 2020

Seth M Steinberg

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25592632 AND SRC:MED&resulttype=core&format=json

28 February 2020

Patrick J Loehrer

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25592632 AND SRC:MED&resulttype=core&format=json

28 February 2020

publication date

13 January 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25592632 AND SRC:MED&resulttype=core&format=json

Lancet Oncology Commission

28 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25592632 AND SRC:MED&resulttype=core&format=json

28 February 2020

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25592632 AND SRC:MED&resulttype=core&format=json

28 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25592632 AND SRC:MED&resulttype=core&format=json

28 February 2020

page(s)

177-186

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25592632 AND SRC:MED&resulttype=core&format=json

Mutations of epigenetic regulatory genes are common in thymic carcinomas

28 February 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4401497

Key components of chemotherapy for thymic malignancies: a systematic review and pooled analysis for anthracycline-, carboplatin- or cisplatin-based chemotherapy.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4401497

Blood-based analyses of cancer: circulating tumor cells and circulating tumor DNA

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4401497

Cixutumumab for patients with recurrent or refractory advanced thymic epithelial tumours: a multicentre, open-label, phase 2 trial

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4401497

Inhibitory Receptor Expression Depends More Dominantly on Differentiation and Activation than "Exhaustion" of Human CD8 T Cells

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4401497

Characterization and management of cardiac involvement of thymic epithelial tumors

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4401497

Thymic Tumors: Relevant Molecular Data in the Clinic

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4401497

Sunitinib in metastatic thymic carcinomas: laboratory findings and initial clinical experience

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4401497

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4401497

The novel role of tyrosine kinase inhibitor in the reversal of immune suppression and modulation of tumor microenvironment for immune-based cancer therapies

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4401497

Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4401497

Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4401497

Recurrent genetic aberrations in thymoma and thymic carcinoma

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4401497

A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4401497

Clinical outcomes with chemotherapy for advanced thymic carcinoma

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4401497

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4401497

Circulating biomarkers in advanced renal cell carcinoma: clinical applications

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4401497

Platelet-derived growth factor and platelet-derived growth factor receptor-α expression in the normal human thymus and thymoma.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4401497

Expression and mutational status of c-kit in thymic epithelial tumors

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4401497

Thirty-five-year follow-up analysis of clinical and pathologic outcomes of thymoma surgery

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4401497

Long lasting response to the multikinase inhibitor bay 43-9006 (Sorafenib) in a heavily pretreated metastatic thymic carcinoma

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4401497

Sunitinib reverses type-1 immune suppression and decreases T-regulatory cells in renal cell carcinoma patients

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4401497

KIT (CD117) is frequently overexpressed in thymic carcinomas but is absent in thymomas

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4401497

Malignant thymoma in the United States: demographic patterns in incidence and associations with subsequent malignancies

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4401497

SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivo

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4401497

Correlation between tumor angiogenesis and invasiveness in thymic epithelial tumors

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4401497

Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: final results of an intergroup trial. The Eastern Cooperative Oncology Group, Southwest Oncology Group, and Southeastern Cancer Study Group

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4401497

Immunohistochemical expression of vascular endothelial growth factor A (VEGF), and its receptors (VEGFR1, 2) in normal and pathologic conditions of the human thymus

26 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1016/S1470-2045(14)71181-7

7 January 2021

inferred from DOI database lookup

Elevated serum vascular endothelial growth factor and basic fibroblast growth factor levels in patients with thymic epithelial neoplasms.

1 reference

Crossref

https://api.crossref.org/works/10.1016/S1470-2045(14)71181-7

7 January 2021

inferred from DOI database lookup

Confidence limits for probability of response in multistage phase II clinical trials

1 reference

Crossref

https://api.crossref.org/works/10.1016/S1470-2045(14)71181-7

7 January 2021

inferred from DOI database lookup

Thymomas alter the T-cell subset composition in the blood: a potential mechanism for thymoma-associated autoimmune disease

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25592632

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1016/S1470-2045(14)71181-7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25592632 AND SRC:MED&resulttype=core&format=json

28 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25592632 AND SRC:MED&resulttype=core&format=json

28 February 2020

PubMed publication ID

25592632

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25592632 AND SRC:MED&resulttype=core&format=json